# A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis

> **NCT00000698** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Cytomegalovirus Retinitis
- HIV Infections

## Interventions

- **DRUG:** Ganciclovir

## Key facts

- **NCT ID:** NCT00000698
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** — (—)
- **Last updated:** 2008-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000698, "A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00000698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*